Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

German bone graft study commences for Aastrom's TRCs

Jan. 26, 2004

New 11beta-HSD1 inhibitors for diabetes, obesity, etc. covered by Merck patent

Jan. 26, 2004

Schering AG claims novel SERM for infertility, menopausal complaints, etc.

Jan. 26, 2004

European phase II trial to test male contraceptive

Jan. 23, 2004

Positive data from first human trial of Alveair insulin pulmonary technology

Jan. 23, 2004

Positive results for Chrysalin in preclinical dental bone formation study

Jan. 23, 2004

Squalene synthase inhibitors for hypercholesterolemia therapy

Jan. 23, 2004

Phase II results of a recombinant human plasma protease C1 inhibitor in hereditary angioedema

Jan. 23, 2004

Nastech begins a clinical trial with intranasal PYY in overweight adults

Jan. 23, 2004

FP-1096 reported safe and effective in ameliorating pain in endometriosis

Jan. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...